Related Experiment Video
Updated: May 30, 2026
07:22
Vein Interposition Model: A Suitable Model to Study Bypass Graft Patency
Published on: January 15, 2017
Reprinted article "Pathophysiology of vein graft failure: a review"
1Vascular Biology and Atherosclerosis Research Laboratory, Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA.
Summary
Vein bypass grafts are crucial for cardiovascular disease but often fail. This review explores vein graft pathology and therapeutic strategies to prevent intimal hyperplasia and atherosclerosis.
Area of Science:
- Cardiovascular Surgery
- Vascular Biology
- Pathology
Background:
- Vein bypass grafting is essential for treating arterial and venous diseases.
- Graft failure due to intrinsic or extrinsic factors is a significant clinical challenge.
Purpose of the Study:
- To review current knowledge on vein graft histology and pathology.
- To assess endothelial and smooth muscle cell physiology and pharmacology in vein grafts.
- To evaluate research on therapeutic control of vein graft intimal hyperplasia and atherosclerosis.
Main Methods:
- Comprehensive literature review of venous histology and pathology.
- Analysis of endothelial and smooth muscle cell function.
- Assessment of current research on therapeutic interventions.
Main Results:
- Vein graft failure is linked to histological and cellular changes.
- Understanding cell physiology and pharmacology is key to graft survival.
- Intimal hyperplasia and atherosclerosis are major pathological processes.
Conclusions:
- Further research into vein graft biology is needed.
- Targeting cellular mechanisms may prevent graft failure.
- Therapeutic strategies are crucial for improving long-term graft patency.
More Related Videos
Related Concept Videos
01:23Peripheral Artery Disease V: Postoperative Nursing Management
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
01:26Varicose Veins I: Introduction
Varicose veins, or varicosities, are abnormally dilated and twisted superficial veins caused by venous valve incompetence. This condition commonly affects the lower extremities, especially the saphenous veins, due to the higher pressure from prolonged standing and walking. However, varicosities can also occur in other areas, such as the esophagus, vulva, spermatic cords, and anorectal region.Etiology and typesPrimary varicose veins, often idiopathic, are more common in women due to inherent...
01:26Varicose Veins II: Diagnostic Studies and Interprofessional Care
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...